Conceptus Stock Hits New 52-Week Low (CPTS)

NEW YORK (TheStreet) -- Conceptus (Nasdaq:CPTS) hit a new 52-week low Tuesday as it is currently trading at $10.15, below its previous 52-week low of $10.22 with 43,115 shares traded as of 11:16 a.m. ET. Average volume has been 370,300 shares over the past 30 days.

Conceptus has a market cap of $332.1 million and is part of the health care sector and health services industry. Shares are down 23.7% year to date as of the close of trading on Monday.

Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications primarily in the United States, France, and Europe. It provides Essure, a permanent birth control system that delivers a soft and flexible insert into a woman's fallopian tubes. The company has a P/E ratio of 4.1, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

• Practice your CPTS trading strategies and win cash in our stock game.

TheStreet Ratings rates Conceptus as a hold. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, notable return on equity and reasonable valuation levels. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year. You can view the full Conceptus Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

For more information on Conceptus Inc. click any of the following:

• Conceptus Inc. Stock Price

• Conceptus Inc. Analyst Ratings

• Conceptus Inc. Key Stats & Profile

• Conceptus Inc. Earnings

• Conceptus Inc. Ratio Comparison

• Conceptus Inc. Growth Rates

• Conceptus Inc. Balance Sheet

• Conceptus Inc. Cash Flow

• Conceptus Inc. Income Statement